After the placement of this first device, the child was discharged under medical treatment. Three years later, the patient's New York Heart Association (NYHA) cardiac functional Class was II-III. Following a risk-benefit analysis, the team elected to attempt surgical closure of the remaining orifices. The closure was performed without cardiopulmonary bypass and was guided by transesophageal echocardiography, with sutures placed below the left anterior descending artery to close the fistulous trajectories [Video 1].
The patient showed clear clinical improvement and was discharged 10 days after surgery. In a follow-up assessment 3 years after surgical closure, the patient's NYHA functional class improved to Class I, and echocardiography showed only a small residual fistula.
In summary, we report the treatment of a coronary artery fistula in an 8-year-old child in Ethiopia using a two-step approach. In many patients, coronary artery fistulae can be treated using either a percutaneous or invasive surgical approach. In clinical settings in which the appropriate technology is not available, a combination of both treatments can be vital for achieving successful treatment.
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[3]
I, therefore, presume that instead of the audiological screening of all KD patients, as recommended by the authors, screening should be reserved for those patients with the aforementioned variables. This appears to be more justifiable and likely to disclose significant SNHL as well as it is cost-effective, particularly in an area with limited resources.
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Sensorineural hearing loss in Kawasaki disease
Sir, Amiodarone is the most commonly used drug in cardiac intensive care unit (ICU) for tachyarrhythmias. Elimination half-life of amiodarone is long and variable; potential for drug interaction exists even when drugs are administered after the discontinuation of amiodarone therapy. Amiodarone toxicity can be accentuated by drugs that interact with its metabolism and elimination such as fluconazole and other drugs. It carries arrhythmogenic potential including lifethreatening heart blocks and increased resistance to cardioversion. [1] [2] [3] Small children are more prone to adverse effects of amiodarone, particularly if they are in a hemodynamically compromised status, as is reported by Saharan et al. [4] Although, procainamide has been mooted as a superior alternative to amiodarone, when treating refractory supraventricular tachyarrhythmias by Chang et al., [5] their adverse effects remain the same. Amiodarone is still "the drug of choice" for arrhythmias in practice today.
We report a case of amiodarone toxicity in pediatric cardiac surgery. Figure 1 ]. The patient responded to intravenous (IV) amiodarone bolus (5 mg/kg), followed by maintenance dose (10 mg/kg/day), and reverted to sinus rhythm. Amiodarone was later continued orally. Routine blood culture grew Candida albicans, for which antifungal IV fluconazole 10 mg/kg/day was given as a single dose infused over 1 h and then continued orally. The child was extubated on the fifth POD, in sinus rhythm. Two-dimensional echocardiography showed improved ventricular function and inotropes were weaned off. On the ninth POD, while removing the internal jugular vein (IJV) line, there was a witnessed bradycardia and arrest needing cardiopulmonary resuscitation (CPR). This precipitous rhythm change was most probably vasovagal bradycardia, leading to AV dissociation with slow ventricular escape rate [ Figure 2 ] not responding to ventricular or AV sequential epicardial pacing [ Figure 3 ]. Circulation was maintained by cardiac massage for 45 min, by which time in response to emergency drugs adrenaline and atropine, the ventricular escape rhythm was stabilized at a higher rate of 100 beats/min. New epicardial pacing wires (both atrial and ventricular) were placed through a subxiphoid exploration, but proved to be ineffective. The child was back on the ventilator with femoral arterial and venous lines were reinserted and on inotropes: Adrenaline (0.05 mcg/kg/min) and
